Day 1 - Thursday 3 February 2022
08.55
|
Welcome
Professor John Plevris, Professor and Consultant in Gastroenterology, Royal Infirmary of Edinburgh
|
Session 1
Chair: Professor John Plevris, Professor and Consultant in Gastroenterology, Royal Infirmary of Edinburgh
09:00
|
GORD: An update in diagnosis and management
Dr Rami Sweis, Consultant Gastroenterologist and Hon Associate Professor, University College Hospital London
|
09:30
|
Emergency upper GI bleeding
Dr Elaine Henry, Consultant Gastroenterologist, Ninewells Hospital and Medical School, Dundee
|
10:00
|
Cytosponge in the diagnosis of oesophagogastric cancer
Dr Massimiliano Di Pietro Consultant Gastroenterologist, Addenbrooke’s Hospital, Cambridge.
|
10:30
|
Break
|
Session 2
Chair: Professor John Plevris, Professor and Consultant in Gastroenterology, Royal Infirmary of Edinburgh
10:45
|
What is new in the management of gastroparesis?
Dr Ian Beales, Consultant Gastroenterologist and Clinical Reader University of East Anglia
|
11:15
|
COVID related gastrointestinal symptoms
Dr Imran Aziz Senior Lecturer & Hon Consultant Gastroenterologist ,Royal Hallamshire Hospital, University of Sheffield
|
11:35
|
Aspects of nutrition in gastrointestinal disease
Dr Ben Shandro, Consultant Gastroenterologist, Royal Infirmary of Edinburgh
|
12:05
|
Role of colon capsule endoscopy vs CT colonography in the diagnosis of colorectal polyps and cancer
Prof Angus Watson Consultant Colorectal Surgeon Hon. Professor of Surgery - University of Aberdeen
Dr Stuart Ballantyre, Consultant Radiologist, Queen Elizabeth University & Greater Glasgow Hospital, Glasgow
|
12:45
|
Lunch
|
Session 3
Chair: Professor Jack Satsangi, Lee Placito Professor of Gastro-intestinal Disease, University of Oxford and Consultant Physician, John Radcliffe Hospital, Oxford
13:45
|
IBD pathogenesis and therapy - Do the answers lie in the microbiome?
Professor Ailsa Hart, Director of IBD Research and Consultant Gastroenterologist, St Mark’s Hospital, Harrow
|
14:10
|
The medical management of Crohn's disease in 2022 - state of the art
Dr Peter Irving, Consultant Gastroenterologist, Guy’s & St Thomas Hospital, London
|
14:35
|
Endoscopy in IBD - state of the art in 2022
Dr Matt Rutter, Consultant Gastroenterologist, University Hospital North Tees, Stockton
|
15:00
|
Break
|
Session 4
Chair: Professor Jack Satsangi, Lee Placito Professor of Gastro-intestinal Disease, University of Oxford and Consultant Physician, John Radcliffe Hospital, Oxford
15:30
|
The medical management of acute severe colitis - state of the art in 2022
Dr Oliver Brain, Consultant Gastroenterologist, John Radcliffe Hospital, Oxford
|
15:55
|
WILFRED (BILL) SIRCUS LECTURE
Chair: Professor Andrew Elder, President, Royal College of Physicians of Edinburgh
The central role of nutritional care in IBD
Dr Alastair McKinlay, Consultant Gastroenterologist, Aberdeen Royal Infirmary
|
16:20
|
Telemedicine in IBD - the future is now
Dr Alissa Walsh, Consultant Gastroenterologist, John Radcliffe Hospital, Oxford
|
16:55
|
Close of day one
|
Day 2 - Friday 4 February 2022
08:55
|
Welcome
Dr Andrew Bathgate, Consultant Hepatologist, Royal Infirmary, Edinburgh |
Session 5
Chair: Dr Andrew Bathgate, Consultant Hepatologist, Royal Infirmary, Edinburgh
09:00
|
Primary biliary cholangitis
Dr Jessica Dyson , Principal Investigator, UK-AIH and Honorary Consultant Hepatologist, Freeman Hospital, Newcastle
|
09:45
|
Alcoholic liver disease
Professor Ewan Forrest, Consultant Hepatologist, Glasgow Royal Infirmary
|
10:30
|
Break
|
Session 6
Chair: Dr Andrew Bathgate, Consultant Hepatologist, Royal Infirmary, Edinburgh
11.00
|
Liver transplantation- what’s new
Dr Timothy Gordon-Walker , Consultant , Scottish Liver Transplant Unit, Royal Infirmary, Edinburgh
|
11.45
|
Viral hepatitis – an update
Dr Stephen Barclay, Consultant Gastroenterologist, Glasgow Royal Infirmary
|
12.30
|
Lunch
|
Session 7
Chair: Professor Adrian Stanley, Consultant Gastroenterologist, Glasgow Royal Infirmary
13:30
|
Non-alcoholic fatty liver disease
Professor Jonathan Fallowfield, Chair of Translational Liver Research and Principal Investigator, University of Edinburgh
|
14:15
|
The lung in liver disease
Dr Martin Johnson, Director, Scottish Pulmonary Vascular Unit, Royal Jubilee Hospital, Clydebank
|
15:00
|
Break
|
Session 8
Chair: Professor Adrian Stanley, Consultant Gastroenterologist, Glasgow Royal Infirmary
15:15
|
Albumin Therapy in Liver disease
Dr Michael Williams, Consultant Hepatologist, Royal Infirmary of Edinburgh
|
16:00
|
Portal hypertension
Professor Peter Hayes, Professor of Hepatology, Royal Infirmary, Edinburgh
|
16:45
|
Close
|